Sellas Life Sciences Group Inc (SLS)
Operating Cash Flow Growth
9.36%
TTM · Period ending:
SLS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported9.36%period ending
Latest reported9.36%period ending
SLS TTM Cash from Operations YoY % (-114.59% → 9.36%)
Year-over-year change
High-resolution chart · PNG
SLS operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 9.3625% | |
| 16.4516% | |
| 19.8096% | |
| 7.4167% | |
| 2.4907% | |
| -12.2054% | |
| -12.7093% | |
| -4.2127% | |
| -5.129% | |
| -4.3702% | |
| -31.9249% | |
| -34.291% | |
| -28.7229% | |
| -25.6921% | |
| 8.5008% | |
| -34.1184% | |
| -54.5993% | |
| -65.2977% | |
| -149.7936% | |
| 2.1979% | |
| 15.5756% | |
| 28.8867% | |
| 40.9568% | |
| 0.0277% | |
| 35.8127% | |
| 35.0783% | |
| 42.0058% | |
| -69.7306% | |
| -940.2274% | |
| -401.169% | |
| -176.8405% | |
| 68.9877% | |
| 93.2117% | |
| 85.7777% | |
| 75.5338% | |
| 34.4087% | |
| 18.7657% | |
| 15.4898% | |
| 6.738% | |
| -19.6703% | |
| -9.2524% | |
| -7.4239% | |
| -12.3423% | |
| -7.4439% | |
| -20.7877% | |
| -46.6466% | |
| -48.2946% | |
| -58.5511% | |
| -72.0017% | |
| -47.7182% | |
| -37.9001% | |
| -28.2559% | |
| -13.4031% | |
| -29.5474% | |
| -42.9166% | |
| -61.4166% | |
| -71.6583% | |
| -52.4539% | |
| -43.0048% | |
| -5.9267% | |
| 10.3421% | |
| 6.074% | |
| 12.8473% | |
| -4.1013% | |
| -18.5358% | |
| -10.6201% | |
| -24.8171% | |
| -26.221% | |
| -21.4788% | |
| -56.8636% | |
| -55.9286% | |
| -114.5858% |